3rd Bacteriophage Therapy Summit 2021 - Boston, MA

Returning in March, the 3rd Bacteriophage Therapy Summit will discuss the characterization, pre-clinical and clinical development, formulation and manufacturing, regulation and the market delivery, this is the end-to-end specialised virtual meeting for you to translate...
Medicine and Me... Medicine and M...
Returning in March, the 3rd Bacteriophage Therapy Summit will discuss the characterization, pre-clinical and clinical development, formulation and manufacturing, regulation and the market delivery, this is the end-to-end specialised virtual meeting for you to translate your bacteriophage research into targeted therapeutics that demonstrate clinically significant results. URLs: Tickets: https:go.evvnt.com709133-2?pid1774 Brochure: https:go.evvnt.com709133-3?pid1774 Prices: Conference Only - Industry Early Bird and group discounts available: USD 1949.0, Conference Only - AcademicStart-Up Early Bird and group discounts available: USD 1499.0 Speakers: Sailaja Puttagunta, CMO, BiomX, Steven Theriault, CEO and CSO, Cytophage, Xavier Duportet, Co-Founder and CEO, Eligo Bioscience, Cara Fiore, Microbiologist, FDA, Office of Vaccines Research and Review, Danish Malik, Reader Industrial Biology, Loughborough University, Saima Aslam, Associate Professor, Division of Infectious Diseases and Global Public Health, iPATH - Center for Innovative Phage Applications and Therapeutics, and more! Time: 08:00 - 17:00
info@hansonwade.com
Online, Online, United States of America